Skip to main content
PLOS One logoLink to PLOS One
. 2026 Mar 16;21(3):e0344798. doi: 10.1371/journal.pone.0344798

Experiences of people living with HIV who have participated in psychological interventions: Protocol for a qualitative meta-analysis

Cristian Ortega 1,2,3,¤a, Jaime Garcia-Iglesias 3,¤b,*, Felipe Concha 1,2,#, Francisca Mena 1,2,, Alemka Tomicic 1,2,
Editor: Satabdi Mitra4
PMCID: PMC12991240  PMID: 41838708

Abstract

Introduction

Mental health problems among people living with HIV have been widely documented, including a high burden of common mental disorders. Despite the demonstrated effectiveness of various psychological interventions, there is limited understanding of how these interventions are experienced and evaluated by participants themselves. A key factor in ensuring successful implementation lies in how individuals interpret and emotionally respond to an intervention—specifically, whether they perceive it as meaningful, appropriate, and aligned with their expectations and needs. This qualitative meta-analysis aims to explore the subjective therapeutic experiences of people living with HIV who have participated in psychological interventions, with a particular focus on their acceptability and the perceived impact on psychological well-being.

Methods and analysis

A qualitative meta-analysis will be conducted following the descriptive-interpretive approach, which enables the identification and synthesis of meaning units from participants’ narratives. The review will include qualitative and mixed-methods studies, with a clearly distinguishable qualitative component, published between January 1, 2000 and February 23, 2026, focusing on the therapeutic experiences of people living with HIV who have received psychological interventions for common mental health problems. A comprehensive search will be performed in MEDLINE (via PubMed), MEDLINE (EBSCOhost), Scopus, Web of Science, APA PsycINFO and SciELO. Methodological quality will be assessed using the CASP tool, and confidence in the findings will be evaluated through GRADE-CERQual. The data analysis will follow the descriptive-interpretive meta-analysis approach. Data management and thematic analysis will be supported by Microsoft Excel, Rayyan and/or ATLAS.ti.

Expected results

This review is expected to identify key experiential themes that reflect how people living with HIV perceive and evaluate psychological interventions, including the aspects they find most helpful, challenging, or relevant. Findings will contribute to a better understanding of the acceptability of such interventions and offer practical insights for improving their design, delivery, and contextual adaptation.

Dissemination

The results of this review will be disseminated through publication in a peer-reviewed journal and presentations at scientific conferences related to mental health, HIV, and qualitative research. The findings are expected to inform the development of more acceptable and culturally sensitive psychological interventions for people living with HIV.

Introduction

Mental health problems among people living with HIV have been widely and systematically reported globally [1,2], with a high burden of common mental disorders and related difficulties in this population [3]. These include depressive and anxiety disorders [4,5], substance use disorders [6], and suicidal ideation [7]. Poorer mental health has been associated with challenges in HIV care and disease management. For example, a study conducted in China [8] reported that depressive symptoms among people living with HIV were associated with poorer antiretroviral therapy (ART) adherence, slower viral suppression, faster progression to AIDS, and higher mortality risk.

Among the psychological mechanisms implicated in common mental health problems among people living with HIV, HIV-related self-stigma has been identified as a key factor. Self-stigma is a socially constructed determinant of mental health and refers to the internalization of negative beliefs, thoughts, and behaviours associated with HIV. It may manifest as shame, guilt, feelings of contamination, self-contempt, low self-esteem, and self-rejection [9]. Higher self-stigma has been linked to poorer health-related quality of life, including more negative illness perceptions and dissatisfaction with sexual and romantic life [1012], as well as reduced adherence to pharmacological treatment [13,14]. Overall, self-stigma may adversely affect both mental and physical health outcomes across diverse sociodemographic groups.

Psychological interventions have shown evidence of effectiveness in addressing mental health problems among people living with HIV, using various therapeutic approaches (e.g., time-limited dynamic psychotherapy [15]; cognitive-behavioral therapy [16]; interpersonal psychotherapy [17]). These interventions have been delivered individually [18] and in groups [19], face-to-face [20] and remotely [21], across urban [22] and rural contexts [23], and among diverse populations (e.g., women, [24] Knettel et al., 2020; gay, bisexual, and other men who have sex with men, [25] Barrington et al., 2023; transgender individuals, [26] Iyer et al., 2024).

In light of the above, it has become increasingly important to adapt psychological interventions that are grounded in empirical evidence, ensuring both their feasibility and acceptability among target populations. For instance, Zhao et al. [27], through a systematic review and meta-analysis, concluded that mind-body therapy, interpersonal psychotherapy, cognitive behavioral therapy, supportive therapy, and educational interventions are effective non-pharmacological approaches for the treatment of depression in this population. However, in terms of acceptability, defined as the extent to which people delivering or receiving a healthcare intervention consider it to be appropriate based on their anticipated or experienced cognitive and emotional responses [28], both supportive therapy and interpersonal psychotherapy were found to be significantly less acceptable than most control conditions. This finding suggests that although certain interventions demonstrate clinical efficacy, they may not be well received by participants, potentially resulting in reduced adherence, discomfort, or negative perceptions of the therapeutic process. Consequently, it is crucial to further explore the conditions under which psychological interventions are deemed acceptable, particularly from the perspective of individuals who experience internalized stigma.

Despite the availability of evidence-based treatments and robust evidence of their effectiveness in managing mental health disorders through objective outcome measures, there remains a limited understanding of the lived experiences of people living with HIV who have participated in psychological interventions. Gaining insight into these experiences is essential to improving the acceptability of such interventions.

Accordingly, the present qualitative meta-analysis aims to systematically identify, synthesize, and critically appraise qualitative evidence on the acceptability of psychological interventions for common mental health problems in people living with HIV. Specifically, it seeks to explore how these interventions are perceived, which elements are considered beneficial or challenging, and how they contribute to psychological well-being, based on participants’ accounts.

To address these gaps, this review will follow the qualitative meta-analysis approach proposed by Timulak and Creaner [29], which emphasizes the systematic identification, categorization, and synthesis of meaning units derived from participants’ narratives. This method is particularly appropriate for exploring subjective experiences, as it allows for the construction of thematic categories grounded in participants expressed perspectives. By applying this meaning-oriented synthesis, the review aims to generate nuanced insights into how people living with HIV experience psychological interventions, and what factors influence their acceptability.

Research objectives

Primary research question.

What are the lived therapeutic experiences of people living with HIV who have participated in psychological interventions, as described in qualitative studies?

Primary objective.

To conduct a qualitative meta-analysis of published research that explores the lived experiences of people living with HIV who have engaged in psychological interventions targeting common mental health problems.

Secondary objectives:

  • To identify the elements of psychological interventions that participants perceive as beneficial or challenging.

  • To understand how these elements influence participants’ psychological well-being, from their own perspectives.

Materials and methods

This qualitative meta-analysis protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO) on June 2, 2025, under the registration number CRD420251065815.

This protocol was developed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) 2015 statement [30], which provides standardized guidance for preparing and reporting systematic review protocols.

Eligibility criteria

To ensure methodological rigor and alignment with the qualitative nature of this review, eligibility criteria will be guided by the SPIDER tool (Sample, Phenomenon of Interest, Design, Evaluation, Research type), which is considered appropriate for identifying relevant qualitative studies [31]. This framework supports the inclusion of studies that emphasize participants’ subjective experiences and meanings—consistent with the objectives of this qualitative meta-analysis and the analytic approach proposed by Timulak and Creaner [29].

Sample (S).

Studies must include adult participants (aged 18 years or older) living with HIV who have received a psychological intervention. There will be no restrictions based on gender, geographic location, cultural background, or risk group (e.g., men who have sex with men, transgender individuals, women, people who use drugs). Studies focusing on key populations particularly affected by HIV will be included, provided they meet the other criteria.

Phenomenon of Interest (PI).

The central phenomenon of interest is the participants’ lived experiences with psychological interventions aimed at addressing common mental health problems—such as depression, anxiety, substance use, or suicidal ideation. The review focuses on how individuals perceive, describe, and make sense of these interventions in the context of their broader experience of living with HIV, including factors related to self-stigma and mental well-being.

Design (D).

Eligible studies must employ a qualitative research design, including but not limited to phenomenology, narrative inquiry, grounded theory, ethnography, or qualitative content analysis. Mixed-methods studies will be included only if they report qualitative data separately and provide sufficient detail to allow for independent extraction and synthesis.

Evaluation (E).

Studies must report participants’ subjective evaluations of the intervention, including perceived acceptability, satisfaction, therapeutic value, challenges, barriers to engagement, emotional responses, or perceived changes in psychological well-being. Studies that only assess intervention effectiveness using quantitative outcomes (e.g., symptom scores) without qualitative insight into participant experience will be excluded.

Research type (R).

This review will include primary qualitative research studies and mixed-methods studies with a clearly defined and analyzable qualitative component. Editorials, theoretical papers, conference abstracts, and purely quantitative studies will be excluded.

Information sources and search strategy

A comprehensive literature search will be conducted using the following electronic databases: MEDLINE (via PubMed), MEDLINE Complete [EBSCOhost]), Web of Science, Scopus, APA PsycINFO, and SciELO. These databases were selected to ensure broad coverage of biomedical, psychological, and social science research relevant to the topic. The search will include peer-reviewed journal articles published in any country and in any language. In addition, the reference lists of all included studies and relevant systematic reviews will be screened for potentially eligible articles. Grey literature (e.g., dissertations, theses, unpublished reports) will not be included, as this review is limited to peer-reviewed qualitative and mixed-methods studies to ensure methodological rigor and reporting quality. The full search strategy developed for MEDLINE Complete (EBSCOhost) is provided in S1 Table. This strategy will be adapted, as appropriate, for the other databases included in the review.

Recognition of the mental health needs of people living with HIV has been increasingly institutionalized since the early 2000s. Both the World Health Organization and UNAIDS have emphasized that mental health is a critical component of comprehensive HIV care, as outlined in key strategic and technical documents [32,33]. Therefore, this review will include studies published between January 1, 2000 and February 23, 2026. This temporal restriction ensures the inclusion of research conducted within contemporary treatment contexts, where the psychological experiences of people living with HIV are shaped by long-term management rather than acute or terminal care settings.

Data management/selection process

The results of the literature search will be imported into Rayyan, a web-based citation management tool designed to facilitate systematic reviews. Duplicate records will be identified and removed prior to screening.

Title and abstract screening will be conducted by two reviewers. The lead reviewer will screen all retrieved records, while two additional reviewers will each independently screen 50% of the records. In this way, all records will be assessed by at least two reviewers to ensure reliability and reduce selection bias. Discrepancies will be resolved through group consensus. If consensus cannot be reached, the record will be retained for full-text screening.

Full-text versions of all potentially eligible studies will be retrieved and independently assessed for inclusion by two reviewers. In cases of disagreement, a third reviewer will be consulted to reach consensus. Reasons for exclusion at the full-text stage will be documented in detail.

The entire selection process will be presented using the PRISMA 2020 flow diagram [34] ensuring transparency and reproducibility.

Data extraction/ data collection

Data will be extracted using a structured form developed in Microsoft Excel. To ensure consistency and reliability, two reviewers will independently extract data from a pilot sample comprising 10% of the included studies. A third reviewer will moderate discrepancies and finalize the extraction framework.

Given the anticipated heterogeneity across studies—in terms of design, populations, intervention types, outcomes, and qualitative data formats—the extraction process will be piloted and iteratively refined as needed during full-text screening.

Once the form has been validated, one reviewer will extract data from the remaining studies. A second reviewer will verify a random subset (at least 20%) to ensure accuracy. Any disagreements will be resolved through discussion or by involving a third reviewer.

Data items

The following data items will be extracted from each included study, where available:

General study characteristics.

Author(s), full citation, study title, journal, publication year, country and study setting, study period, funding sources, declaration of competing interests, study design or methodology, duration, and number and timing of follow-ups.

Participant characteristics.

Description of the study population, including subpopulation or risk group (e.g., MSM, transgender women, women living with HIV), sample size (at baseline, post-intervention, and follow-up), age range, gender, ethnicity, method of recruitment, inclusion/exclusion criteria (especially those related to mental health conditions such as depression, anxiety, substance use, or suicidal ideation), and comorbidities.

Intervention characteristics.

Description of the psychological intervention including its theoretical framework or orientation (e.g., CBT, interpersonal psychotherapy), delivery format (individual or group), setting (in-person, remote, or blended), platform/tools used (e.g., websites, SMS, mobile apps), number and duration of sessions, providers/facilitators involved.

Evaluation and outcome information.

Data related to participant-reported experiences and evaluations of the intervention (or elements thereof), including perceived acceptability, usefulness, feasibility, accessibility, emotional or cognitive responses, facilitators and barriers, drop-out rates, and usability feedback. Where reported, relevant outcome measures (e.g., symptom reduction or service user satisfaction) will also be recorded, although these will be interpreted qualitatively rather than quantitatively.

Outcomes and prioritisation

The primary outcome of this qualitative meta-analysis is the perceived acceptability of psychological interventions targeting common mental health problems (e.g., depression, anxiety, substance use, and suicidal ideation) among people living with HIV. Acceptability will be defined according to the framework proposed by Sekhon et al. [28] as the extent to which individuals delivering or receiving a healthcare intervention consider it appropriate, based on anticipated or experienced cognitive and emotional responses. This may be reported through participants’ own reflections on emotional engagement, satisfaction, perceived usefulness, burden, intervention coherence, ethical alignment, and self-efficacy.

Secondary outcomes will include:

  • a)

    Participants’ evaluations of the psychological impact of the intervention on their mental health and overall well-being, including experiences of change or stability in symptoms, coping skills, or stigma;

  • b)

    Experiences related to the accessibility, feasibility, and contextual relevance of the intervention, such as barriers to engagement, facilitators, or preferences for format and delivery mode (e.g., remote vs. in-person);

  • c)

    Interpersonal or relational outcomes, such as perceived support, therapeutic alliance, or group cohesion;

  • d)

    Broader social or structural experiences that influence engagement with psychological interventions, including stigma, discrimination, or intersectional vulnerabilities (e.g., gender identity, substance use, socioeconomic status).

Risk of bias in individual studies

To assess the risk of bias in individual studies, the Critical Appraisal Skills Programme (CASP) checklist for qualitative research [35] will be used. This tool evaluates key methodological domains, including clarity of research aims, appropriateness of the design, recruitment strategy, data collection methods, consideration of the researcher-participant relationship, ethical issues, data analysis rigor, and transparency in reporting findings.

Two reviewers will independently appraise each included study using the CASP tool. Disagreements will be discussed and resolved through consensus, with a third reviewer consulted if necessary. While no study will be excluded based solely on its appraisal score, the results of the critical appraisal will be used to contextualize the findings of the synthesis and to assess the credibility, transferability, and dependability of the evidence.

A summary of the CASP appraisal ratings will be provided in a supplementary table for transparency.

Data analysis and synthesis methods

The data analysis will follow the descriptive-interpretive meta-analysis approach proposed by Timulak and Creaner [29], which emphasizes the identification, organization, and synthesis of meaning units derived from participants’ narratives. This approach is particularly well-suited for capturing the experiential and contextual richness of qualitative data while preserving participants’ voices.

The meta-analysis will be conducted through the following steps:

  • 1

    Familiarization with the data

All qualitative findings (i.e., results sections, themes, and direct quotations) will be read thoroughly to achieve immersion in the data and contextual understanding of each study.

  • 2

    Identification of meaning units

Discrete segments of text (meaning units) that reflect significant aspects of participants’ experiences with psychological interventions will be extracted. These units may include participant quotes or author interpretations and will be treated as the basic elements of synthesis.

  • 3

    Preliminary categorization

Meaning units will be grouped into lower-order categories based on thematic similarity. These categories will remain close to the participants’ original expressions and language.

  • 4

    Construction of core categories and interpretive themes

Through iterative comparison and abstraction, core categories will be developed by grouping lower-order categories that reflect broader patterns across studies. Interpretive themes will be defined and refined collaboratively by the review team.

  • 5

    Cross-case analysis and interpretation

Themes will be compared across studies to explore contextual patterns (e.g., intervention type, population subgroup, delivery mode) and to identify similarities, divergences, or emerging subthemes. When possible, subgroup-specific patterns (e.g., by gender identity, sexual orientation, or substance use) will be explored to identify contextual differences in the acceptability and perceived impact of psychological interventions.

The meta-analysis will be managed and organized using Microsoft Excel and/or ATLAS.ti software, depending on the complexity of the dataset. Two reviewers will collaborate on the analysis process to ensure rigor and reflexivity. Discrepancies in interpretation will be resolved through discussion or adjudicated by a third reviewer if necessary. The goal of the qualitative meta-analysis is to generate an in-depth understanding of the acceptability and experiential impact of psychological interventions among people living with HIV, contributing to more context-sensitive and person-centered intervention design.

Meta-bias

Potential qualitative meta-analysis bias will be mitigated through:

  • a)

    Comprehensive search strategy, including multiple databases and backward citation tracking to reduce the risk of missing relevant studies.

  • b)

    The inclusion of studies regardless of quality appraisal score, while using CASP results to contextualize the weight and credibility of findings.

  • c)

    Transparent reporting of the meta-analytic process, including how meaning units and themes were developed, how disagreements were resolved, and how researchers’ interpretations were checked for reflexivity.

Confidence in cumulative estimate

The confidence in the findings of this qualitative evidence will be assessed using the GRADE-CERQual (Confidence in the Evidence from Reviews of Qualitative Research) approach, which provides a transparent and systematic method for evaluating the trustworthiness of individual review findings [36].

CERQual assesses four components for each synthesized finding:

  • 1

    Methodological limitations

The extent to which problems in the design or conduct of the primary studies may decrease confidence in the finding. This will be informed by the results of the CASP appraisal.

  • 2

    Coherence

The degree to which the data supporting the review finding are consistent and well-explained across multiple studies.

  • 3

    Adequacy of data

The richness and quantity of data supporting each review finding, including the number of studies, participants, and contexts represented.

  • 4

    Relevance

The extent to which the evidence supporting a review finding is applicable to the context specified in the review question (e.g., people living with HIV who have received psychological interventions for common mental health problems).

Each synthesized finding will be assigned an overall level of confidence: high, moderate, low, or very low. These ratings will be justified and summarized in a CERQual Summary of Qualitative Findings (SoQF) table, following the recommended template by the GRADE-CERQual group.

Study status and estimated timeline

At the time of submission, this review is in its preparatory phase. No formal data collection, screening, or data extraction has yet been conducted. Only preliminary searches have been performed across the selected databases to refine the search strategy and eligibility criteria.

The planned timeline for the review is as follows:

  • •Record screening: Expected to begin in March 2025 and to be completed by April 2026.

  • •Full-text review and data extraction: To commence in April 2026 and conclude by May 2026.

  • •Data synthesis and manuscript preparation: To take place between June and August 2026.

  • •Submission of the results manuscript: Anticipated for September 2026.

The timeline may be adjusted if necessary to maintain methodological rigor and ensure comprehensive coverage of the qualitative evidence base. All methodological procedures—including record screening, data extraction, and synthesis—will be conducted according to the protocol described in this document.

Discussion

This qualitative meta-analysis seeks to address a critical gap in the literature by exploring how people living with HIV experience psychological interventions aimed at common mental health problems. While existing evidence highlights the effectiveness of various psychotherapeutic approaches, their acceptability from the perspective of participants—particularly those affected by self-stigma—remains poorly understood. By synthesizing first-person narratives, this review will provide valuable insights into what makes interventions feel appropriate, helpful, or challenging. The use of Timulak and Creaner’s meaning-oriented synthesis allows for an in-depth understanding of participants’ lived experiences across diverse contexts and populations. Findings will inform the design and delivery of more acceptable and person-centered psychological interventions. In doing so, this study may contribute to improving adherence, engagement, and long-term mental health outcomes in people living with HIV.

Supporting information

S1 Table. Full SPIDER-based search strategy for MEDLINE Complete (EBSCOhost).

(PDF)

pone.0344798.s001.pdf (90KB, pdf)
S1 File. Prisma.

(DOCX)

pone.0344798.s002.docx (29.4KB, docx)

Data Availability

No datasets were generated or analyzed during the study as this is a literature review protocol. All relevant information is within the paper and its Supporting Information file.

Funding Statement

This Qualitative Meta-Analysis is funded by University Diego Portales, Centre of Research in Clinical Psychology and Psychotherapy (CEPPS) and ANID – Millennium Science Initiative Program / Millennium Institute for Research on Depression and Personality - MIDAP AIM23_0002 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.National Institutes of Health. HIV and mental health. HIVinfo. 2024. [Cited 2025 July 10]. https://hivinfo.nih.gov/understanding-hiv/fact-sheets/hiv-and-mental-health [Google Scholar]
  • 2.O’Cleirigh C, Magidson JF, Skeer MR, Mayer KH, Safren SA. Prevalence of psychiatric and substance abuse symptomatology among HIV-infected gay and bisexual men in HIV primary care. Psychosomatics. 2015;56(5):470–8. doi: 10.1016/j.psym.2014.08.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Hoare J, Sevenoaks T, Mtukushe B, Williams T, Heany S, Phillips N. Global systematic review of common mental health disorders in adults living with HIV. Curr HIV/AIDS Rep. 2021;18(6):569–80. doi: 10.1007/s11904-021-00583-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Xiao L, Qi H, Wang Y-Y, Wang D, Wilkinson M, Hall BJ, et al. The prevalence of depression in men who have sex with men (MSM) living with HIV: A meta-analysis of comparative and epidemiological studies. Gen Hosp Psychiatry. 2020;66:112–9. doi: 10.1016/j.genhosppsych.2020.04.001 [DOI] [PubMed] [Google Scholar]
  • 5.Aunon FM, Simoni JM, Yang JP, Shiu C, Chen W-T, Edmunds SR, et al. Depression and anxiety among HIV-positive men who have sex with men and men who have sex with women in China. AIDS Care. 2020;32(3):362–9. doi: 10.1080/09540121.2019.1683803 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Ollero MJF, Ryan P, Dolengevich-Segal H, Cano-Smith J, Ramos-Ruperto L, Cabello A, et al. Drug addiction in gay and bisexual men living with HIV engaged in sexualized drug use: recent drug use, polydrug and depressive symptoms as predictors. AIDS Behav. 2025;29(7):2324–35. doi: 10.1007/s10461-025-04695-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Li S, Yu S, Yang Q, Yin J, Zhu H, Jiang Y, et al. Prevalence of suicide ideation among HIV/AIDS patients in China: A systematic review and meta-analysis. Front Public Health. 2023;11:1082521. doi: 10.3389/fpubh.2023.1082521 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Fu H, Feng T, Wang T, Wu X, Cai Y, Yang T. Reported prevalence of depression or depressive symptoms among men who have sex with men in China, 2004-2018: A systematic review and meta-analysis. J Affect Disord. 2020;277:192–203. doi: 10.1016/j.jad.2020.08.011 [DOI] [PubMed] [Google Scholar]
  • 9.Ferris France N, Lyons S, Cioringa A, Mavhu W, Manas Miramontes I, Byrne E. Interventions to reduce self-stigma among people living with HIV: A systematic review. Stigma and Health. 2025. doi: 10.1037/sah0000600 [DOI] [Google Scholar]
  • 10.Osei-Yeboah J, Owiredu WKBA, Norgbe GK, Lokpo SY, Obirikorang C, Alote Allotey E, et al. Quality of life of people living with HIV/AIDS in the ho municipality, Ghana: A cross-sectional study. AIDS Res Treat. 2017;2017:6806951. doi: 10.1155/2017/6806951 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Nigusso FT, Mavhandu-Mudzusi AH. Health-related quality of life of people living with HIV/AIDS: the role of social inequalities and disease-related factors. Health Qual Life Outcomes. 2021;19(1):63. doi: 10.1186/s12955-021-01702-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ortega C, Tomicic A. “Ese golpe que uno recibe”: Estudio cualitativo del diagnóstico reciente de VIH en hombres gay. ATHENEAD. 2025;25(3):e3708. doi: 10.5565/rev/athenea.3708 [DOI] [Google Scholar]
  • 13.Onu DU. Treatment adherence mediates the relationship between HIV-related stigma and health-related quality of life. AIDS Care. 2021;33(10):1335–9. doi: 10.1080/09540121.2020.1867701 [DOI] [PubMed] [Google Scholar]
  • 14.Perger T, Davtyan M, Foster C, Evangeli M, Berman C, Kacanek D, et al. Impact of HIV-related stigma on antiretroviral therapy adherence, engagement and retention in HIV care, and transition to adult HIV care in pediatric and young adult populations living with HIV: A literature review. AIDS Behav. 2025;29(2):497–516. doi: 10.1007/s10461-024-04534-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Pobuda T, Crothers L, Goldblum P, Dilley JW, Koopman C. Effects of time-limited dynamic psychotherapy on distress among HIV-seropositive men who have sex with men. AIDS Patient Care STDS. 2008;22(7):561–7. doi: 10.1089/apc.2007.0250 [DOI] [PubMed] [Google Scholar]
  • 16.Kustanti A, Mahendradhata Y, Aulawi K. A scoping review: Cognitive Behavior Therapy (CBT) in self stigma for people living with HIV (PLHIV). Journal of HIV/AIDS & Social Services. 2024;23(1):51–74. doi: 10.1080/15381501.2024.2422081 [DOI] [Google Scholar]
  • 17.Yator O, Khasakhala L, Stewart G-J, Kumar M. Acceptability and impact of group interpersonal therapy (IPT-G) on Kenyan adolescent mothers living with human immunodeficiency virus (HIV): a qualitative analysis. BMC Womens Health. 2022;22(1):240. doi: 10.1186/s12905-022-01807-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Perry NS, Remmert JE, Psaros C, Pinkston M, Safren SA. Learning to address multiple syndemics for people living with HIV through client perspectives on CBT. Psychother Res. 2019;29(4):492–502. doi: 10.1080/10503307.2017.1380863 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Magnolini R, Staehelin S, Senkoro E, Kruijver M, Krinke E, Weisser M. Effectiveness and acceptance of group therapy as a mental health intervention for people living with HIV in Africa - a scoping literature review. AIDS Care. 2024;36(7):870–84. doi: 10.1080/09540121.2023.2298779 [DOI] [PubMed] [Google Scholar]
  • 20.Chawla S, Kaida A, Brouillette M-J, Kleiner B, Dubuc D, Skerritt L, et al. Impact of mental health service use on the HIV care cascade among women. HIV Med. 2025;26(5):758–72. doi: 10.1111/hiv.70008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Glasner S, Patrick K, Ybarra M, Reback CJ, Ang A, Kalichman S, et al. Promising outcomes from a cognitive behavioral therapy text-messaging intervention targeting drug use, antiretroviral therapy adherence, and HIV risk behaviors among adults living with HIV and substance use disorders. Drug Alcohol Depend. 2022;231:109229. doi: 10.1016/j.drugalcdep.2021.109229 [DOI] [PubMed] [Google Scholar]
  • 22.Miles DRB, Bilal U, Hutton HE, Lau B, Lesko CR, Fojo A, et al. Tobacco smoking, substance use, and mental health symptoms in people with HIV in an Urban HIV Clinic. J Health Care Poor Underserved. 2019;30(3):1083–102. doi: 10.1353/hpu.2019.0075 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Anderson T, McClintock AS, McCarrick SS, Heckman TG, Heckman BD, Markowitz JC, et al. Working alliance, interpersonal problems, and depressive symptoms in tele-interpersonal psychotherapy for HIV-infected rural persons: evidence for indirect effects. J Clin Psychol. 2018;74(3):286–303. doi: 10.1002/jclp.22502 [DOI] [PubMed] [Google Scholar]
  • 24.Knettel BA, Robertson C, Ciya N, Coleman JN, Elliott SA, Joska JA, et al. “I cannot change what happened to me, but I can learn to change how I feel”: A case study from ImpACT, an intervention for women with a history of sexual trauma who are living with HIV in Cape Town, South Africa. Psychotherapy (Chic). 2020;57(1):90–6. doi: 10.1037/pst0000263 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Barrington C, Davis DA, Angeles G, Pajarito Rompich AY, Santa Luce R, Shelus V, et al. HIV treatment and mental health outcomes among gay, bisexual, and other men who have sex with men living with HIV in a pilot multicomponent intervention in Guatemala City. Health Educ Behav. 2023;50(6):758–69. doi: 10.1177/10901981231164598 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Iyer H, Underhill A, Persad Y, Lacombe-Duncan A, Kennedy VL, Nation K, et al. Operationalizing the Women-Centred HIV Care Model for trans women and persons with transfeminine experience living with and affected by HIV: A qualitative study. Int J Transgend Health. 2024;26(4):1070–92. doi: 10.1080/26895269.2024.2323508 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Zhao T, Tang C, Yan H, Lu Q, Guo M, Wang H. Comparative efficacy and acceptability of non-pharmacological interventions for depression in people living with HIV: A systematic review and network meta-analysis. Int J Nurs Stud. 2023;140:104452. doi: 10.1016/j.ijnurstu.2023.104452 [DOI] [PubMed] [Google Scholar]
  • 28.Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare interventions: a theoretical framework and proposed research agenda. BMC Health Serv Res. 2017;17(1):88. doi: 10.1186/s12913-017-2031-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Timulak L, Creaner M. Essentials of qualitative meta-analysis. Washington (DC): American Psychological Association; 2023. [Google Scholar]
  • 30.Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349(jan02 1):g7647–g7647. doi: 10.1136/bmj.g7647 [DOI] [PubMed] [Google Scholar]
  • 31.Cooke A, Smith D, Booth A. Beyond PICO: the SPIDER tool for qualitative evidence synthesis. Qual Health Res. 2012;22(10):1435–43. doi: 10.1177/1049732312452938 [DOI] [PubMed] [Google Scholar]
  • 32.World Health Organization, Wonca. Integrating mental health into primary care: a global perspective. Geneva: World Health Organization; 2008. https://www.who.int/publications/i/item/9789241563680 [Google Scholar]
  • 33.UNAIDS. End inequalities. End AIDS. Global AIDS Strategy 2021–2026. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS); 2021. https://www.unaids.org/en/resources/documents/2021/2021-2026-global-aids-strategy [Google Scholar]
  • 34.Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Critical Appraisal Skills Programme (CASP). CASP qualitative checklist. 2018. [Cited 2026 February 23]. https://casp-uk.net/casp-tools-checklists/
  • 36.Lewin S, Glenton C, Munthe-Kaas H, Carlsen B, Colvin CJ, Gulmezoglu M, et al. PLOS Medicine Staff. Correction: Using Qualitative Evidence in Decision Making for Health and Social Interventions: An Approach to Assess Confidence in Findings from Qualitative Evidence Syntheses (GRADE-CERQual). PLoS Med. 2016;13(6):e1002065. doi: 10.1371/journal.pmed.1002065 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Satabdi Mitra

5 Feb 2026

Dear Dr.  Garcia-Iglesias,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 22 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Satabdi Mitra, M.D(Community Medicine )

Academic Editor

PLOS One

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following financial disclosure:

“This Qualitative Meta-Analysis is funded by University Diego Portales, Centre of Research in Clinical Psychology and Psychotherapy (CEPPS) and ANID – Millennium Science Initiative Program / Millennium Institute for Research on Depression and Personality - MIDAP AIM23_0002”

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

3. Please provide a complete Data Availability Statement in the submission form, ensuring you include all necessary access information or a reason for why you are unable to make your data freely accessible. If your research concerns only data provided within your submission, please write "All data are in the manuscript and/or supporting information files" as your Data Availability Statement.

4. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.

5. Please amend either the abstract on the online submission form (via Edit Submission) or the abstract in the manuscript so that they are identical.

6. Please include a copy of Table 1 which you refer to in your text on page 8.

7. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information .

8. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

9. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

Reviewer #1: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses??>

Reviewer #1: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable??>

Reviewer #1: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete??>

The PLOS Data policy

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

**********

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

Reviewer #1: This protocol addresses an important gap in HIV care by focusing on the subjective "acceptability" and lived experiences of participants in psychological interventions. The methodology is reasonably robust and well prepared.

However, there is a significant discrepancy regarding the inclusion period for studies. The abstract states the review will include studies published within the last 10 years , whereas the methods section specifies a limit of the last 25 years to reflect contemporary treatment contexts.

I am of opinion that the protocol is suitable for publication once this is addressed

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

PLoS One. 2026 Mar 16;21(3):e0344798. doi: 10.1371/journal.pone.0344798.r002

Author response to Decision Letter 1


23 Feb 2026

We sincerely thank you and the reviewer for the careful evaluation of our manuscript and for the positive and constructive feedback.

We are pleased that the reviewer considered the research question valid, the methodology technically sound, and the protocol sufficiently detailed and replicable.

Reviewer #1 noted a discrepancy between the time frame described in the abstract (10 years) and that described in the Methods section (25 years). We have carefully reviewed the manuscript and corrected this inconsistency. The abstract has been revised to specify that the review will include studies published between January 1, 2000 and February 23, 2026, consistent with the Methods section.

In addition, we have addressed all journal requirements outlined in the decision letter, including:

• Updating the Role of Funder statement to comply with PLOS ONE guidelines.

• Providing a complete Data Availability Statement in the submission form.

• Ensuring that the abstract in the manuscript and submission system are identical.

• Including the detailed MEDLINE (EBSCOhost) search strategy as S1 Table.

• Adding Supporting Information captions at the end of the manuscript.

• Reviewing and standardizing all references according to PLOS ONE formatting guidelines.

We believe that these revisions fully address the reviewer’s comment and the journal requirements. We thank you again for your consideration.

Attachment

Submitted filename: Response to Reviewers 11-02-26.docx

pone.0344798.s004.docx (15.5KB, docx)

Decision Letter 1

Satabdi Mitra

26 Feb 2026

Experiences of people living with HIV who have participated in psychological interventions: Protocol for a Qualitative Meta-Analysis

PONE-D-25-38173R1

Dear Dr. Jaime Garcia-Iglesias,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Satabdi Mitra, M.D(Community Medicine )

Academic Editor

PLOS One

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Satabdi Mitra

PONE-D-25-38173R1

PLOS One

Dear Dr. Garcia-Iglesias,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr Satabdi Mitra

Academic Editor

PLOS One

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Full SPIDER-based search strategy for MEDLINE Complete (EBSCOhost).

    (PDF)

    pone.0344798.s001.pdf (90KB, pdf)
    S1 File. Prisma.

    (DOCX)

    pone.0344798.s002.docx (29.4KB, docx)
    Attachment

    Submitted filename: Response to Reviewers 11-02-26.docx

    pone.0344798.s004.docx (15.5KB, docx)

    Data Availability Statement

    No datasets were generated or analyzed during the study as this is a literature review protocol. All relevant information is within the paper and its Supporting Information file.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES